DGX - NYSE

Quest Diagnostics Incorporated

DGX·NYSE

$193.67

+0.26%

HealthcareMedical - Diagnostics & Research

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$21.44B

EPS8.8700

P/E Ratio21.83

Earnings Date07/28/2026

16.23B

Assets

3Y+26.0%

5Y+16.0%

10Y+61.0%

8.94B

Total Liabilities

-3%

3Y+31.0%

5Y+25.0%

10Y+67.0%

7.29B

Total Equity

3Y+21.0%

5Y+6.0%

10Y+54.0%

Quest Diagnostics Incorporated Funding & Solvency Profile

DGX · NYSE

Current Assets

Cash & Cash Equivalents420.00M

Net Receivables1.41B

Inventory189.00M

Other Current Assets361.00M

Total Current Assets2 B

Non-Current Assets

Property, Plant & Equipment2.86B

Goodwill & Intangible Assets10.58B

Long-Term Investments136.00M

Other Non-Current Assets270.00M

Total Non-Current Assets3 B

Total Assets

16.23B

Financial Health Analysis

Current Ratio

1.04x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

1.23x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

100 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

15% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Quest Diagnostics Incorporated Balance Sheet

DGX • NYSE

Quest Diagnostics Incorporated Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	420M	549M	686M	315M	872M	1.2B	1.2B	135M	137M	359M	133M	192M	187M	295.6M	164.9M	449.3M	534.3M	253.9M	167.6M	149.6M
Cash & Short-Term Investments	420M	549M	686M	315M	872M	1.2B	1.2B	135M	137M	359M	133M	192M	187M	295.6M	164.9M	449.3M	534.3M	253.9M	167.6M	149.6M
Net Receivables	1.4B	1.3B	1.2B	1.2B	1.4B	1.5B	1.1B	1B	924M	926M	901M	932M	852M	867M	906.5M	845.3M	827.3M	832.9M	882M	774.4M
Accounts Receivables	1.4B	1.3B	1.2B	1.2B	1.4B	1.5B	1.1B	1B	924M	926M	901M	932M	852M	867M	906.5M	845.3M	827.3M	832.9M	882M	774.4M
Inventory	189M	188M	190M	192M	208M	223M	123M	99M	95M	82M	84M	110M	91M	93.1M	89.1M	76.6M	91.4M	102.1M	95.2M	78.6M
Prepaids	0.0	0.0	0.0	0.0	223M	157M	112M	144M	150M	155M	41M	44M	105M	91M	87.5M	91.8M	94.6M	89.5M	79.7M	67.9M
Other Current Assets	361M	351M	286M	196M	0.0	0.0	0.0	0.0	0.0	9M	176M	183M	148M	214M	153.3M	142.5M	131.8M	218.4M	149.8M	120.5M
Total Current Assets	2.4B	2.4B	2.4B	1.9B	2.7B	3.1B	2.5B	1.4B	1.3B	1.5B	1.5B	1.6B	1.4B	1.6B	1.4B	1.6B	1.7B	1.5B	1.4B	1.2B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.9B	2.8B	2.4B	2.4B	2.3B	2.2B	2B	1.3B	1.1B	1B	925M	933M	805M	755.8M	799.8M	834.4M	825.9M	879.7M	912M	752.4M
Goodwill	8.9B	8.9B	7.7B	7.2B	7.1B	6.9B	6.6B	6.6B	6.3B	6B	5.9B	6B	5.6B	5.5B	5.8B	5.1B	5.1B	5.1B	5.2B	3.4B
Intangible Assets	1.6B	1.8B	1.2B	1.1B	1.2B	1.2B	1.1B	1.2B	1.1B	949M	984M	1.1B	896M	872.2M	1B	796.4M	823.7M	827.4M	886.7M	193.3M
Goodwill & Intangible Assets	10.6B	10.6B	8.9B	8.3B	8.3B	8B	7.7B	7.8B	7.5B	6.9B	6.9B	7.1B	6.5B	6.4B	6.8B	5.9B	5.9B	5.9B	6.1B	3.6B
Long-Term Investments	136M	123M	135M	132M	141M	521M	482M	436M	462M	443M	473M	46M	-148M	-174.2M	0.0	0.0	0.0	-218.4M	0.0	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4M	32M	0.0	-46M	148M	174.2M	0.0	0.0	0.0	218.4M	0.0	0.0
Other Non-Current Assets	270M	255M	198M	144M	163M	176M	160M	119M	132M	116M	174M	238M	215M	559M	281M	189.5M	150.7M	145M	172.5M	133.7M
Total Non-Current Assets	13.8B	13.8B	11.7B	10.9B	10.9B	11B	10.4B	9.6B	9.2B	8.6B	8.5B	8.3B	7.6B	7.7B	7.9B	6.9B	6.9B	6.9B	7.2B	4.5B
Total Assets	16.2B	16.2B	14B	12.8B	13.6B	14B	12.8B	11B	10.5B	10.1B	10B	9.9B	8.9B	9.3B	9.3B	8.5B	8.6B	8.4B	8.6B	5.7B
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.6B	287M	378M	326M	367M	489M	290M	239M	233M	264M	283M	320M	265M	281.4M	215.3M	212.5M	207.3M	191.2M	205.1M	215.7M
Accounts Payable	1.6B	287M	378M	324M	357M	446M	263M	222M	224M	261M	279M	257M	258M	203.5M	215.3M	212.5M	207.3M	191.2M	205.1M	215.7M
Other Payables	0.0	0.0	0.0	2M	10M	43M	27M	17M	9M	3M	4M	63M	7M	77.8M	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	479M	381M	428M	518M	502M	287M	249M	325M	316M	305M	364M	283M	335M	339.8M	298.8M	349.3M	299.4M	318.3M	321.5M
Short Term Debt	678M	937M	585M	247M	269M	296M	1B	562M	107M	6M	159M	518M	212M	9.4M	654.4M	349M	170.5M	5.1M	163.6M	316.9M
Tax Payables	0.0	0.0	0.0	2M	10M	43M	27M	17M	9M	3M	4M	63M	7M	77.8M	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	0.0	466M	471M	550M	599M	489M	376M	435M	392M	395M	426M	507M	372M	421.8M	351.7M	353.9M	332.1M	729M	601.4M	296.7M
Total Current Liabilities	2.3B	2.2B	1.8B	1.6B	1.8B	1.8B	2B	1.5B	1.1B	981M	1.2B	1.7B	1.1B	1B	1.6B	1.2B	1.1B	1.2B	1.3B	1.2B
NON-CURRENT LIABILITIES
Long Term Debt	5.7B	5.6B	4.4B	4B	4B	4B	3.9B	3.4B	3.7B	3.7B	3.5B	3.2B	3.1B	3.3B	3.3B	2.6B	2.9B	3.1B	3.4B	1.2B
Deferred Tax Liabilities (Non-Current)	0.0	250M	270M	295M	290M	350M	264M	243M	170M	191M	157M	204M	192M	187M	184M	193M	0.0	0.0	0.0	21M
Other Non-Current Liabilities	420M	688M	606M	517M	502M	497M	447M	502M	493M	463M	357M	369M	531M	509.4M	482.7M	425.1M	556.2M	496.1M	575.9M	231.3M
Total Non-Current Liabilities	6.7B	7.1B	5.8B	5.3B	5.3B	5.4B	5.1B	4.2B	4.4B	4.4B	4B	3.8B	3.8B	4.1B	4B	3.3B	3.5B	3.6B	4B	1.5B
Capital Lease Obligations	537M	551M	503M	489M	494M	524M	558M	32M	0.0	7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	8.9B	9.3B	7.6B	6.8B	7B	7.1B	7.1B	5.7B	5.5B	5.4B	5.2B	5.5B	5B	5.1B	5.6B	4.5B	4.6B	4.8B	5.2B	2.6B
SHAREHOLDERS' EQUITY
Treasury Stock	-5.2B	-4.9B	-4.8B	-4.7B	-3.5B	-5.4B	-5.2B	-5B	-4.8B	-4.5B	-4B	-3.8B	-3.8B	-2.9B	-2.9B	-2.2B	-1.5B	-1.2B	-971.7M	-968.2M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2K	6K	8K	80K	56K	0.0	0.0
Common Stock	2M	2M	2M	2M	2M	2M	2M	2M	2M	2M	2M	2M	2M	2.2M	2.1M	2.1M	2.1M	2.1M	2.1M	2.1M
Additional Paid-In Capital	2.4B	2.4B	2.3B	2.3B	2.3B	2.8B	2.7B	2.7B	2.6B	2.5B	2.5B	2.4B	2.4B	2.4B	2.3B	2.3B	2.3B	2.3B	2.2B	2.2B
Retained Earnings	10B	9.4B	8.8B	8.3B	7.6B	9.3B	8.2B	7.6B	7.1B	6.6B	6.2B	5.7B	5.4B	4.7B	4.3B	3.9B	3.2B	2.6B	2.1B	1.8B
Accumulated Other Comprehensive Income/Loss	-27M	-88M	-14M	-21M	-14M	-21M	-39M	-59M	-48M	-72M	-38M	-27M	-8M	14.3M	-8M	10.6M	-21M	-68.1M	25.3M	-65K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100K	0.0	0.0	78K	0.0	0.0	0.0
Total Stockholders' Equity	7.2B	6.8B	6.3B	5.9B	6.4B	6.8B	5.6B	5.2B	4.9B	4.6B	4.7B	4.3B	3.9B	4.2B	3.7B	4B	4B	3.6B	3.3B	3B
Total Equity	7.3B	6.9B	6.4B	6B	6.6B	6.9B	5.8B	5.3B	5B	4.7B	4.8B	4.3B	4B	4.2B	3.7B	4.1B	4B	3.6B	3.3B	3B
Minority Interest	116M	118M	111M	114M	118M	132M	122M	128M	114M	109M	99M	29M	25M	22.7M	22.1M	20.6M	21.8M	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	16.2B	16.2B	14B	12.8B	13.6B	14B	12.8B	11B	10.5B	10.1B	10B	9.9B	8.9B	9.3B	9.3B	8.5B	8.6B	8.4B	8.6B	5.7B
Total Investments	136M	123M	135M	132M	141M	521M	482M	436M	462M	443M	473M	46M	-148M	-174.2M	0.0	0.0	0.0	-218.4M	0.0	0.0
Total Debt	6.9B	7.1B	5.5B	4.7B	4.8B	4.8B	5.4B	4B	3.9B	3.7B	3.7B	3.8B	3.3B	3.4B	4B	3B	3.1B	3.1B	3.5B	1.6B
Net Debt	6.5B	6.5B	4.8B	4.4B	3.9B	3.7B	4.2B	3.9B	3.7B	3.4B	3.5B	3.6B	3.1B	3.1B	3.9B	2.5B	2.6B	2.8B	3.4B	1.4B
Shares Outstanding	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679	111,749,679

SEC Filings

DGX - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 21, 2026	May 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 08, 2026	May 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 01, 2026	April 27, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 22, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 21, 2026	April 21, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 06, 2026	May 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 12, 2026	March 09, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 10, 2026	February 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing

Showing 1 to 10 of 471 filings

Related Guides

Blog Categories

Continue your DGX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.